17β-Estradiol reduces stroke injury in estrogen-deficient female animals

Renata Rusa, Nabil J. Alkayed, Barbara J. Crain, Richard J. Traystman, Alane S. Kimes, Edythe D. London, Judy A. Klaus, Patricia D. Hurn

Research output: Contribution to journalArticle

Abstract

Background and Purpose - The importance of postmenopausal estrogen replacement therapy for stroke in females remains controversial. We previously showed that female rats sustain less infarction in reversible middle cerebral artery occlusion (MCAO) than their ovariectomized counterparts and that vascular mechanisms are partly responsible for improved tissue outcomes. Furthermore, exogenous estrogen strongly protects the male brain, even when administered in a single injection before MCAO injection. The present study examined the hypothesis that replacement of 17β-estradiol to physiological levels improves stroke outcome in ovariectomized, estrogen- deficient female rats, acting through blood flow-mediated mechanisms. Methods - Age-matched, adult female Wistar rats were ovariectomized and treated with 0, 25, or 100 μg of 17 β-estradiol administered through a subcutaneous implant or with a single Premarin (USP) injection (1 mg/kg) given immediately before ischemia was induced (n=10 per group). Each animal subsequently underwent 2 hours of MCAO by the intraluminal filament technique, followed by 22 hours of reperfusion. Ipsilateral parietal cortex perfusion was monitored by laser-Doppler flowmetry throughout ischemia. Cortical and caudate-putamen infarction volumes were determined by 2,3,5-triphenyltetrazolium chloride staining and digital image analysis. End-ischemic regional cerebral blood flow was measured in ovariectomized females with 0- or 25-μg implants (n=4 per group) by 14C-iodoantipyrine quantitative autoradiography. Results - Plasma estradiol levels were 3.0±0.6, 20±8, and 46±10 pg/mL in the 0-, 25- , and 100-μg groups, respectively. Caudate-putamen infarction (% of ipsilateral Caudate-putamen) was reduced by long-term, 25-μg estrogen treatment (13±4% versus 31±6% in the 0-μg group, P

Original languageEnglish (US)
Pages (from-to)1665-1670
Number of pages6
JournalStroke
Volume30
Issue number8
StatePublished - Aug 1999

Fingerprint

Estradiol
Estrogens
Stroke
Middle Cerebral Artery Infarction
Putamen
Infarction
Wounds and Injuries
Injections
Cerebrovascular Circulation
Ischemia
Conjugated (USP) Estrogens
Parietal Lobe
Laser-Doppler Flowmetry
Estrogen Replacement Therapy
Regional Blood Flow
Autoradiography
Reperfusion
Blood Vessels
Wistar Rats
Perfusion

Keywords

  • 17β-estradiol
  • Cerebral blood flow
  • Cerebral ischemia
  • Estrogen replacement therapy
  • Rats
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Rusa, R., Alkayed, N. J., Crain, B. J., Traystman, R. J., Kimes, A. S., London, E. D., ... Hurn, P. D. (1999). 17β-Estradiol reduces stroke injury in estrogen-deficient female animals. Stroke, 30(8), 1665-1670.

17β-Estradiol reduces stroke injury in estrogen-deficient female animals. / Rusa, Renata; Alkayed, Nabil J.; Crain, Barbara J.; Traystman, Richard J.; Kimes, Alane S.; London, Edythe D.; Klaus, Judy A.; Hurn, Patricia D.

In: Stroke, Vol. 30, No. 8, 08.1999, p. 1665-1670.

Research output: Contribution to journalArticle

Rusa, R, Alkayed, NJ, Crain, BJ, Traystman, RJ, Kimes, AS, London, ED, Klaus, JA & Hurn, PD 1999, '17β-Estradiol reduces stroke injury in estrogen-deficient female animals', Stroke, vol. 30, no. 8, pp. 1665-1670.
Rusa R, Alkayed NJ, Crain BJ, Traystman RJ, Kimes AS, London ED et al. 17β-Estradiol reduces stroke injury in estrogen-deficient female animals. Stroke. 1999 Aug;30(8):1665-1670.
Rusa, Renata ; Alkayed, Nabil J. ; Crain, Barbara J. ; Traystman, Richard J. ; Kimes, Alane S. ; London, Edythe D. ; Klaus, Judy A. ; Hurn, Patricia D. / 17β-Estradiol reduces stroke injury in estrogen-deficient female animals. In: Stroke. 1999 ; Vol. 30, No. 8. pp. 1665-1670.
@article{d5c709de349d4db886a1935d14b05b26,
title = "17β-Estradiol reduces stroke injury in estrogen-deficient female animals",
abstract = "Background and Purpose - The importance of postmenopausal estrogen replacement therapy for stroke in females remains controversial. We previously showed that female rats sustain less infarction in reversible middle cerebral artery occlusion (MCAO) than their ovariectomized counterparts and that vascular mechanisms are partly responsible for improved tissue outcomes. Furthermore, exogenous estrogen strongly protects the male brain, even when administered in a single injection before MCAO injection. The present study examined the hypothesis that replacement of 17β-estradiol to physiological levels improves stroke outcome in ovariectomized, estrogen- deficient female rats, acting through blood flow-mediated mechanisms. Methods - Age-matched, adult female Wistar rats were ovariectomized and treated with 0, 25, or 100 μg of 17 β-estradiol administered through a subcutaneous implant or with a single Premarin (USP) injection (1 mg/kg) given immediately before ischemia was induced (n=10 per group). Each animal subsequently underwent 2 hours of MCAO by the intraluminal filament technique, followed by 22 hours of reperfusion. Ipsilateral parietal cortex perfusion was monitored by laser-Doppler flowmetry throughout ischemia. Cortical and caudate-putamen infarction volumes were determined by 2,3,5-triphenyltetrazolium chloride staining and digital image analysis. End-ischemic regional cerebral blood flow was measured in ovariectomized females with 0- or 25-μg implants (n=4 per group) by 14C-iodoantipyrine quantitative autoradiography. Results - Plasma estradiol levels were 3.0±0.6, 20±8, and 46±10 pg/mL in the 0-, 25- , and 100-μg groups, respectively. Caudate-putamen infarction ({\%} of ipsilateral Caudate-putamen) was reduced by long-term, 25-μg estrogen treatment (13±4{\%} versus 31±6{\%} in the 0-μg group, P",
keywords = "17β-estradiol, Cerebral blood flow, Cerebral ischemia, Estrogen replacement therapy, Rats, Stroke",
author = "Renata Rusa and Alkayed, {Nabil J.} and Crain, {Barbara J.} and Traystman, {Richard J.} and Kimes, {Alane S.} and London, {Edythe D.} and Klaus, {Judy A.} and Hurn, {Patricia D.}",
year = "1999",
month = "8",
language = "English (US)",
volume = "30",
pages = "1665--1670",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - 17β-Estradiol reduces stroke injury in estrogen-deficient female animals

AU - Rusa, Renata

AU - Alkayed, Nabil J.

AU - Crain, Barbara J.

AU - Traystman, Richard J.

AU - Kimes, Alane S.

AU - London, Edythe D.

AU - Klaus, Judy A.

AU - Hurn, Patricia D.

PY - 1999/8

Y1 - 1999/8

N2 - Background and Purpose - The importance of postmenopausal estrogen replacement therapy for stroke in females remains controversial. We previously showed that female rats sustain less infarction in reversible middle cerebral artery occlusion (MCAO) than their ovariectomized counterparts and that vascular mechanisms are partly responsible for improved tissue outcomes. Furthermore, exogenous estrogen strongly protects the male brain, even when administered in a single injection before MCAO injection. The present study examined the hypothesis that replacement of 17β-estradiol to physiological levels improves stroke outcome in ovariectomized, estrogen- deficient female rats, acting through blood flow-mediated mechanisms. Methods - Age-matched, adult female Wistar rats were ovariectomized and treated with 0, 25, or 100 μg of 17 β-estradiol administered through a subcutaneous implant or with a single Premarin (USP) injection (1 mg/kg) given immediately before ischemia was induced (n=10 per group). Each animal subsequently underwent 2 hours of MCAO by the intraluminal filament technique, followed by 22 hours of reperfusion. Ipsilateral parietal cortex perfusion was monitored by laser-Doppler flowmetry throughout ischemia. Cortical and caudate-putamen infarction volumes were determined by 2,3,5-triphenyltetrazolium chloride staining and digital image analysis. End-ischemic regional cerebral blood flow was measured in ovariectomized females with 0- or 25-μg implants (n=4 per group) by 14C-iodoantipyrine quantitative autoradiography. Results - Plasma estradiol levels were 3.0±0.6, 20±8, and 46±10 pg/mL in the 0-, 25- , and 100-μg groups, respectively. Caudate-putamen infarction (% of ipsilateral Caudate-putamen) was reduced by long-term, 25-μg estrogen treatment (13±4% versus 31±6% in the 0-μg group, P

AB - Background and Purpose - The importance of postmenopausal estrogen replacement therapy for stroke in females remains controversial. We previously showed that female rats sustain less infarction in reversible middle cerebral artery occlusion (MCAO) than their ovariectomized counterparts and that vascular mechanisms are partly responsible for improved tissue outcomes. Furthermore, exogenous estrogen strongly protects the male brain, even when administered in a single injection before MCAO injection. The present study examined the hypothesis that replacement of 17β-estradiol to physiological levels improves stroke outcome in ovariectomized, estrogen- deficient female rats, acting through blood flow-mediated mechanisms. Methods - Age-matched, adult female Wistar rats were ovariectomized and treated with 0, 25, or 100 μg of 17 β-estradiol administered through a subcutaneous implant or with a single Premarin (USP) injection (1 mg/kg) given immediately before ischemia was induced (n=10 per group). Each animal subsequently underwent 2 hours of MCAO by the intraluminal filament technique, followed by 22 hours of reperfusion. Ipsilateral parietal cortex perfusion was monitored by laser-Doppler flowmetry throughout ischemia. Cortical and caudate-putamen infarction volumes were determined by 2,3,5-triphenyltetrazolium chloride staining and digital image analysis. End-ischemic regional cerebral blood flow was measured in ovariectomized females with 0- or 25-μg implants (n=4 per group) by 14C-iodoantipyrine quantitative autoradiography. Results - Plasma estradiol levels were 3.0±0.6, 20±8, and 46±10 pg/mL in the 0-, 25- , and 100-μg groups, respectively. Caudate-putamen infarction (% of ipsilateral Caudate-putamen) was reduced by long-term, 25-μg estrogen treatment (13±4% versus 31±6% in the 0-μg group, P

KW - 17β-estradiol

KW - Cerebral blood flow

KW - Cerebral ischemia

KW - Estrogen replacement therapy

KW - Rats

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0032587611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032587611&partnerID=8YFLogxK

M3 - Article

C2 - 10436119

AN - SCOPUS:0032587611

VL - 30

SP - 1665

EP - 1670

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 8

ER -